376270 — HEM Pharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual cashflow statement for HEM Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	—	-13,009	-11,667	-7,646	-23,724
Depreciation
Amortisation
Non-Cash Items	—	1,295	4,132	1,343	9,239
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-7,540	-1,864	-186	-3,798	3,545
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-7,540	-11,131	-5,269	-7,680	-8,345
Capital Expenditures	-7,188	-10,270	-4,541	-4,798	-9,985
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,883	-6,507	16,815	-4,675	4,414
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-10,071	-16,777	12,274	-9,473	-5,571
Financing Cash Flow Items	-2.23	-5.12	-3.17	-915	-5.54
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	6,999	19,011	-1,014	15,272	21,425
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-10,602	-8,898	5,991	-1,877	7,511